• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    7.25 Down 0.10(1.29%) Dec 19, 4:00PM EST
    |After Hours : 7.25 Up 0.00 (0.06%) Dec 19, 5:35PM EST
    Add to Portfolio
    Prev Close:7.35
    Open:7.34
    Bid:6.75 x 1100
    Ask:N/A
    1y Target Est:7.50
    Beta:2.45
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:7.21 - 7.57
    52wk Range:3.10 - 7.57
    Volume:6,108,494
    Avg Vol (3m):1,105,300
    Market Cap:504.27M
    P/E (ttm):60.42
    EPS (ttm):0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 1.29%504.27M
    DNDN 0.00%N/A
    NKTRUp 0.48%2.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.13
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):2.26

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback